Incorporating InPen and CGM for the optimization of MDI therapy

Chair: Robert Vigersky (USA)

19:30 – 19:40The need and clinical evidenceRobert Vigersky (USA)
19:40 – 20:00Case Presentation in Type 1 and Type 2 diabetesAnders Carlson (USA)